DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

Novo Nordisk stock slumped early Monday as the drugmaker was facing a potential hit to revenue from several different ...

Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...

Novo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...

A view of the logo of Novo Nordisk A/S at the headquarters in Bagsværd. Novo Nordisk A/S is a Danish multinational ...

Shares rallied Wednesday even after the drugmaker lowered its full-year guidance as alternative versions of its blockbuster ...

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

The S&P 500 rose in choppy trading after the Federal Reserve signaled that the risks for an economic slowdown and higher ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.